Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Outcomes of Patients with Unfavorable Stage I-II Classic Hodgkin Lymphoma Treated with Stanford V Chemotherapy and Limited Irradiation Weil, C., Qian, Y., Von Eyben, R., Daadi, S. E., Corbelli, K. S., Rosenberg, S. A., Advani, R. H., Hoppe, R. T. ELSEVIER SCIENCE INC. 2018: S189
View details for DOI 10.1016/j.ijrobp.2018.07.076
View details for Web of Science ID 000447811602641